p53信号通路基因多态性与COPD患者肺气肿改变相关
该研究纳入365例有吸烟史的患者,检测p53与MDM2基因多态性,用CT评估肺气肿程度,并分析吸烟者肺组织中SNP、MDM2 mRNA与p53蛋白水平;细胞实验用p53/MDM2 SNP质粒转染人肺成纤维细胞并加香烟烟雾提取物,发现两基因多态性与肺气肿改变及凋亡信号相关。
要点
- p53与MDM2基因多态性与吸烟者肺气肿改变相关
- 多态性同时关联肺组织p53蛋白与MDM2 mRNA表达
- MDM2 SNP309启动子活性可被香烟烟雾提取物改变
核心结论
- p53和MDM2基因多态性与凋亡信号及吸烟相关肺气肿改变相关。
研究设计与样本
- 纳入365例有吸烟史患者,检测p53与MDM2基因多态性,并用CT判定肺气肿程度。
- 评估吸烟者人肺组织中SNP、MDM2 mRNA与p53蛋白水平。
- 用编码p53与MDM2 SNP的质粒转染人肺成纤维细胞,加或不加香烟烟雾提取物,测细胞增殖与MDM2启动子活性。
主要发现
- p53与MDM2基因多态性与肺部肺气肿改变相关。
- 两基因多态性也与肺组织样本中p53蛋白和MDM2 mRNA表达相关。
- 转染p53基因编码质粒可调节人肺成纤维细胞增殖。
- 在编码MDM2 SNP309的人肺成纤维细胞中,香烟烟雾提取物改变了P2启动子活性。
临床怎么用
- 对有吸烟史人群可关注p53与MDM2多态性作为肺气肿易感性的研究线索。
- 解读时需结合CT肺气肿评估与肺组织表达水平,不宜单独用于临床决策。
局限性
- 摘要未报告具体基因型分布、效应量、P值及多因素校正结果。
- 细胞实验使用质粒转染与香烟烟雾提取物,外推至临床需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The p53 signaling pathway may be important for the pathogenesis of emphysematous changes in the lungs of smokers. Polymorphism of p53 at codon 72 is known to affect apoptotic effector proteins, and the polymorphism of mouse double minute 2 homolog (MDM2) single nucleotide polymorphism (SNP)309 is known to increase MDM2 expression. The aim of this study was to assess polymorphisms of the p53 and MDM2 genes in smokers and confirm the role of SNPs in these genes in the pathogenesis of pulmonary emphysema. METHODS: This study included 365 patients with a smoking history, and the polymorphisms of p53 and MDM2 genes were identified. The degree of pulmonary emphysema was determined by means of CT scanning. SNPs, MDM2 mRNA, and p53 protein levels were assessed in human lung tissues from smokers. Plasmids encoding p53 and MDM2 SNPs were used to transfect human lung fibroblasts (HLFs) with or without cigarette smoke extract (CSE), and the effects on cell proliferation and MDM2 promoter activity were measured. RESULTS: The polymorphisms of the p53 and MDM2 genes were associated with emphysematous changes in the lung and were also associated with p53 protein and MDM2 mRNA expression in the lung tissue samples. Transfection with a p53 gene-coding plasmid regulated HLF proliferation, and the analysis of P2 promoter activity in MDM2 SNP309-coding HLFs showed the promoter activity was altered by CSE. CONCLUSIONS: Our data demonstrated that p53 and MDM2 gene polymorphisms are associated with apoptotic signaling and smoking-related emphysematous changes in lungs from smokers.
引用
- Mizuno S, Ishizaki T, Kadowaki M, et al. p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD. Chest. 2017. PMID: 28315337. doi:10.1016/j.chest.2017.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。